

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 4.39597660 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.39597660 |
| 3 | alpha-linolenic acid metabolic process (GO:0036109) | 4.33788830 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.33612847 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 4.33612847 |
| 6 | kynurenine metabolic process (GO:0070189) | 4.20527113 |
| 7 | glycine metabolic process (GO:0006544) | 4.15860199 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.12248694 |
| 9 | sulfur amino acid catabolic process (GO:0000098) | 4.09841669 |
| 10 | aromatic amino acid family catabolic process (GO:0009074) | 4.09113785 |
| 11 | serine family amino acid catabolic process (GO:0009071) | 4.07272610 |
| 12 | negative regulation of cholesterol transport (GO:0032375) | 4.06202439 |
| 13 | negative regulation of sterol transport (GO:0032372) | 4.06202439 |
| 14 | mitotic sister chromatid cohesion (GO:0007064) | 4.02712594 |
| 15 | urea metabolic process (GO:0019627) | 3.87780817 |
| 16 | urea cycle (GO:0000050) | 3.87780817 |
| 17 | cysteine metabolic process (GO:0006534) | 3.87548294 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 3.86022077 |
| 19 | tryptophan catabolic process (GO:0006569) | 3.84633165 |
| 20 | indole-containing compound catabolic process (GO:0042436) | 3.84633165 |
| 21 | indolalkylamine catabolic process (GO:0046218) | 3.84633165 |
| 22 | NADH metabolic process (GO:0006734) | 3.83084406 |
| 23 | lysine metabolic process (GO:0006553) | 3.82770200 |
| 24 | lysine catabolic process (GO:0006554) | 3.82770200 |
| 25 | glyoxylate metabolic process (GO:0046487) | 3.81529719 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.73637384 |
| 27 | protein carboxylation (GO:0018214) | 3.73637384 |
| 28 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.70750207 |
| 29 | regulation of cholesterol homeostasis (GO:2000188) | 3.69100232 |
| 30 | tryptophan metabolic process (GO:0006568) | 3.64175395 |
| 31 | regulation of RNA export from nucleus (GO:0046831) | 3.59408391 |
| 32 | triglyceride catabolic process (GO:0019433) | 3.58177885 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.53185182 |
| 34 | fatty acid homeostasis (GO:0055089) | 3.52134965 |
| 35 | complement activation, alternative pathway (GO:0006957) | 3.46167714 |
| 36 | high-density lipoprotein particle remodeling (GO:0034375) | 3.45545891 |
| 37 | nitrogen cycle metabolic process (GO:0071941) | 3.44680924 |
| 38 | serine family amino acid metabolic process (GO:0009069) | 3.44407531 |
| 39 | regulation of protein activation cascade (GO:2000257) | 3.42254944 |
| 40 | mRNA stabilization (GO:0048255) | 3.41056889 |
| 41 | RNA stabilization (GO:0043489) | 3.41056889 |
| 42 | histone H3-K36 demethylation (GO:0070544) | 3.40524261 |
| 43 | regulation of fibrinolysis (GO:0051917) | 3.38004721 |
| 44 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.37970874 |
| 45 | homocysteine metabolic process (GO:0050667) | 3.35854738 |
| 46 | bile acid biosynthetic process (GO:0006699) | 3.35791426 |
| 47 | neutral lipid catabolic process (GO:0046461) | 3.34927390 |
| 48 | acylglycerol catabolic process (GO:0046464) | 3.34927390 |
| 49 | embryonic process involved in female pregnancy (GO:0060136) | 3.31843356 |
| 50 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.30286767 |
| 51 | trophectodermal cell differentiation (GO:0001829) | 3.30096689 |
| 52 | lipoprotein transport (GO:0042953) | 3.28756334 |
| 53 | amino-acid betaine metabolic process (GO:0006577) | 3.27852134 |
| 54 | serine family amino acid biosynthetic process (GO:0009070) | 3.27357141 |
| 55 | carnitine shuttle (GO:0006853) | 3.20879832 |
| 56 | regulation of SMAD protein import into nucleus (GO:0060390) | 3.20828295 |
| 57 | regulation of complement activation (GO:0030449) | 3.19736764 |
| 58 | 2-oxoglutarate metabolic process (GO:0006103) | 3.11809872 |
| 59 | cellular modified amino acid catabolic process (GO:0042219) | 3.11136886 |
| 60 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.10382322 |
| 61 | NLS-bearing protein import into nucleus (GO:0006607) | 3.10179197 |
| 62 | regulation of triglyceride catabolic process (GO:0010896) | 3.09964824 |
| 63 | acylglycerol homeostasis (GO:0055090) | 3.06935491 |
| 64 | triglyceride homeostasis (GO:0070328) | 3.06935491 |
| 65 | imidazole-containing compound metabolic process (GO:0052803) | 3.05404068 |
| 66 | diacylglycerol metabolic process (GO:0046339) | 3.05160995 |
| 67 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.05031891 |
| 68 | bile acid metabolic process (GO:0008206) | 3.04898339 |
| 69 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.04818738 |
| 70 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.03958558 |
| 71 | low-density lipoprotein particle clearance (GO:0034383) | 3.03151592 |
| 72 | pre-miRNA processing (GO:0031054) | 3.01440949 |
| 73 | alpha-amino acid catabolic process (GO:1901606) | 3.01251785 |
| 74 | regulation of chromatin silencing (GO:0031935) | 3.01242459 |
| 75 | positive regulation of catenin import into nucleus (GO:0035413) | 3.00469248 |
| 76 | tricarboxylic acid metabolic process (GO:0072350) | 2.99369511 |
| 77 | valine metabolic process (GO:0006573) | 2.98744373 |
| 78 | plasma lipoprotein particle assembly (GO:0034377) | 2.98225501 |
| 79 | ethanol oxidation (GO:0006069) | 2.98109335 |
| 80 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.97375767 |
| 81 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.95636618 |
| 82 | hippo signaling (GO:0035329) | 2.94646333 |
| 83 | cellular protein complex localization (GO:0034629) | 2.94585575 |
| 84 | plasma lipoprotein particle clearance (GO:0034381) | 2.93353186 |
| 85 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.92279573 |
| 86 | histone H4-K12 acetylation (GO:0043983) | 2.91413375 |
| 87 | tetrahydrofolate metabolic process (GO:0046653) | 2.89683561 |
| 88 | bile acid and bile salt transport (GO:0015721) | 2.86367726 |
| 89 | reverse cholesterol transport (GO:0043691) | 2.84554014 |
| 90 | regulation of stem cell maintenance (GO:2000036) | 2.83732234 |
| 91 | negative regulation of lipase activity (GO:0060192) | 2.83688943 |
| 92 | one-carbon metabolic process (GO:0006730) | 2.83344834 |
| 93 | cellular amino acid catabolic process (GO:0009063) | 2.82529346 |
| 94 | aromatic amino acid family metabolic process (GO:0009072) | 2.81852290 |
| 95 | protein-lipid complex remodeling (GO:0034368) | 2.81490764 |
| 96 | macromolecular complex remodeling (GO:0034367) | 2.81490764 |
| 97 | plasma lipoprotein particle remodeling (GO:0034369) | 2.81490764 |
| 98 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.81436814 |
| 99 | regulation of gene silencing by miRNA (GO:0060964) | 2.81436814 |
| 100 | regulation of gene silencing by RNA (GO:0060966) | 2.81436814 |
| 101 | nucleosome disassembly (GO:0006337) | 2.80866282 |
| 102 | protein-DNA complex disassembly (GO:0032986) | 2.80866282 |
| 103 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.79803080 |
| 104 | regulation of translational fidelity (GO:0006450) | 2.78006983 |
| 105 | protein complex localization (GO:0031503) | 2.77837104 |
| 106 | regulation of bile acid biosynthetic process (GO:0070857) | 2.76211352 |
| 107 | cellular ketone body metabolic process (GO:0046950) | 2.75208619 |
| 108 | negative regulation of DNA repair (GO:0045738) | 2.74085881 |
| 109 | protein-lipid complex assembly (GO:0065005) | 2.73357210 |
| 110 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.72541904 |
| 111 | biotin metabolic process (GO:0006768) | 2.71284618 |
| 112 | polyol transport (GO:0015791) | 2.70662105 |
| 113 | phospholipid efflux (GO:0033700) | 2.70480190 |
| 114 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.69925726 |
| 115 | triglyceride biosynthetic process (GO:0019432) | 2.66986401 |
| 116 | acetyl-CoA metabolic process (GO:0006084) | 2.66689275 |
| 117 | L-serine metabolic process (GO:0006563) | 2.66407071 |
| 118 | protein localization to microtubule (GO:0035372) | 2.64081151 |
| 119 | regulation of cholesterol esterification (GO:0010872) | 2.63628023 |
| 120 | notochord development (GO:0030903) | 2.63000911 |
| 121 | positive regulation of lipid catabolic process (GO:0050996) | 2.62942761 |
| 122 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.62005875 |
| 123 | nuclear pore complex assembly (GO:0051292) | 2.60309070 |
| 124 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.59933353 |
| 125 | intestinal cholesterol absorption (GO:0030299) | 2.59309032 |
| 126 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.59209210 |
| 127 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.59209210 |
| 128 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.59209210 |
| 129 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.59133342 |
| 130 | tyrosine metabolic process (GO:0006570) | 2.58834529 |
| 131 | glutamate metabolic process (GO:0006536) | 2.58171869 |
| 132 | gastrulation with mouth forming second (GO:0001702) | 2.57263244 |
| 133 | benzene-containing compound metabolic process (GO:0042537) | 2.56818549 |
| 134 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.56656482 |
| 135 | nuclear pore organization (GO:0006999) | 2.56333030 |
| 136 | transcytosis (GO:0045056) | 2.55206816 |
| 137 | DNA unwinding involved in DNA replication (GO:0006268) | 2.55083047 |
| 138 | cholesterol homeostasis (GO:0042632) | 2.53990019 |
| 139 | regulation of cell fate specification (GO:0042659) | 2.53659845 |
| 140 | thioester biosynthetic process (GO:0035384) | 2.52296111 |
| 141 | acyl-CoA biosynthetic process (GO:0071616) | 2.52296111 |
| 142 | mitotic chromosome condensation (GO:0007076) | 2.51759853 |
| 143 | neutral lipid biosynthetic process (GO:0046460) | 2.51412279 |
| 144 | acylglycerol biosynthetic process (GO:0046463) | 2.51412279 |
| 145 | sterol homeostasis (GO:0055092) | 2.50988597 |
| 146 | paraxial mesoderm development (GO:0048339) | 2.50879826 |
| 147 | 4-hydroxyproline metabolic process (GO:0019471) | 2.50796307 |
| 148 | phospholipid homeostasis (GO:0055091) | 2.50717872 |
| 149 | convergent extension (GO:0060026) | 2.50347872 |
| 150 | intestinal absorption (GO:0050892) | 2.50343814 |
| 151 | adherens junction assembly (GO:0034333) | 2.50282151 |
| 152 | response to epidermal growth factor (GO:0070849) | 2.50232182 |
| 153 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.50075564 |
| 154 | cellular hyperosmotic response (GO:0071474) | 2.48840575 |
| 155 | fatty acid transmembrane transport (GO:1902001) | 2.48605074 |
| 156 | epoxygenase P450 pathway (GO:0019373) | 2.48429162 |
| 157 | indolalkylamine metabolic process (GO:0006586) | 2.46763723 |
| 158 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.46485286 |
| 159 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.46308678 |
| 160 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.46148934 |
| 161 | aspartate family amino acid catabolic process (GO:0009068) | 2.46112391 |
| 162 | heterochromatin organization (GO:0070828) | 2.45355391 |
| 163 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.44866238 |
| 164 | triglyceride metabolic process (GO:0006641) | 2.44730546 |
| 165 | cholesterol efflux (GO:0033344) | 2.44676828 |
| 166 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.44092720 |
| 167 | carnitine transport (GO:0015879) | 2.43336695 |
| 168 | amino-acid betaine transport (GO:0015838) | 2.43336695 |
| 169 | negative regulation of lipid transport (GO:0032369) | 2.43085145 |
| 170 | positive regulation of histone deacetylation (GO:0031065) | 2.42511091 |
| 171 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.42190614 |
| 172 | oxaloacetate metabolic process (GO:0006107) | 2.41475948 |
| 173 | cytolysis (GO:0019835) | 2.41343511 |
| 174 | maternal placenta development (GO:0001893) | 2.40869594 |
| 175 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.40040532 |
| 176 | DNA topological change (GO:0006265) | 2.38678013 |
| 177 | regulation of sequestering of triglyceride (GO:0010889) | 2.38245065 |
| 178 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.37919209 |
| 179 | negative regulation of gene silencing (GO:0060969) | 2.37847747 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.47116185 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.91279457 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.88706454 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.78831809 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.30327350 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.20080119 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 3.05555853 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.91558638 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.55105906 |
| 10 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 2.46142112 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.42705724 |
| 12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.42354408 |
| 13 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.41473750 |
| 14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.31387558 |
| 15 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.29922479 |
| 16 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.19922965 |
| 17 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.17485066 |
| 18 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.16367268 |
| 19 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.03835910 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.03079027 |
| 21 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 2.00448435 |
| 22 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.95602727 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.86173346 |
| 24 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.85889318 |
| 25 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.83275549 |
| 26 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.82247486 |
| 27 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.81861817 |
| 28 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.81797681 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.80947175 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.80484372 |
| 31 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.79267181 |
| 32 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.79250094 |
| 33 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.75711937 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.72637578 |
| 35 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.69219130 |
| 36 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68611060 |
| 37 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.60030994 |
| 38 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.56658152 |
| 39 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.52720875 |
| 40 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.51363762 |
| 41 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.51169035 |
| 42 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.50449404 |
| 43 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.49192320 |
| 44 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42990107 |
| 45 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40340157 |
| 46 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.40007442 |
| 47 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.38248827 |
| 48 | MAF_26560356_Chip-Seq_TH1_Human | 1.37740826 |
| 49 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.36817445 |
| 50 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.36240003 |
| 51 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.33960835 |
| 52 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.33082541 |
| 53 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.32547156 |
| 54 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.32035422 |
| 55 | UTX_26944678_Chip-Seq_JUKART_Human | 1.30208711 |
| 56 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.27206392 |
| 57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.26986693 |
| 58 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.26865611 |
| 59 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.24982395 |
| 60 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.24982395 |
| 61 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.24929581 |
| 62 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.24573278 |
| 63 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.24487518 |
| 64 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24053891 |
| 65 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23566766 |
| 66 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.23533636 |
| 67 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.23271122 |
| 68 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.21488829 |
| 69 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.21186851 |
| 70 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.21169145 |
| 71 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20863781 |
| 72 | * POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.19934644 |
| 73 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.18136283 |
| 74 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17155623 |
| 75 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.16753328 |
| 76 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16302302 |
| 77 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.16232143 |
| 78 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.15470380 |
| 79 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.15254200 |
| 80 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.14838223 |
| 81 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.14500985 |
| 82 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.14232710 |
| 83 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13868749 |
| 84 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.13608359 |
| 85 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.13452949 |
| 86 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.10850380 |
| 87 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.10651433 |
| 88 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.10384805 |
| 89 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.08991430 |
| 90 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.08840200 |
| 91 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.07212285 |
| 92 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07061631 |
| 93 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.06552763 |
| 94 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05320874 |
| 95 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.05309791 |
| 96 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.05198151 |
| 97 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.05011057 |
| 98 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.04450364 |
| 99 | ATF3_27146783_Chip-Seq_COLON_Human | 1.04061529 |
| 100 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04050784 |
| 101 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.03731966 |
| 102 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.03443317 |
| 103 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.02379867 |
| 104 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.02363081 |
| 105 | MAF_26560356_Chip-Seq_TH2_Human | 1.01062560 |
| 106 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.00746920 |
| 107 | MYB_26560356_Chip-Seq_TH1_Human | 0.99928446 |
| 108 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.99403482 |
| 109 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.98969907 |
| 110 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.98936576 |
| 111 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98415546 |
| 112 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.98261289 |
| 113 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.97839374 |
| 114 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97610925 |
| 115 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97512040 |
| 116 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.97308180 |
| 117 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.95912474 |
| 118 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.95661033 |
| 119 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.95553361 |
| 120 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.95139367 |
| 121 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95053867 |
| 122 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94706131 |
| 123 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94358285 |
| 124 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.93936394 |
| 125 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.93827635 |
| 126 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.93112717 |
| 127 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.92608375 |
| 128 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.91965114 |
| 129 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.91713041 |
| 130 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.91611132 |
| 131 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90626642 |
| 132 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.90013379 |
| 133 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.89877019 |
| 134 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.89517201 |
| 135 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.89483058 |
| 136 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.88810929 |
| 137 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88710951 |
| 138 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88109791 |
| 139 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.87335970 |
| 140 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.86354056 |
| 141 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.85341323 |
| 142 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.85341323 |
| 143 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.85341323 |
| 144 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.85095012 |
| 145 | MYB_26560356_Chip-Seq_TH2_Human | 0.83528927 |
| 146 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.83273561 |
| 147 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.82932253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.03472980 |
| 2 | MP0005360_urolithiasis | 4.94279967 |
| 3 | MP0005365_abnormal_bile_salt | 4.20391546 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.80606540 |
| 5 | MP0002009_preneoplasia | 2.88008305 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 2.80087829 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.78632008 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.69735744 |
| 9 | MP0003252_abnormal_bile_duct | 2.62577989 |
| 10 | MP0009840_abnormal_foam_cell | 2.52810969 |
| 11 | MP0005409_darkened_coat_color | 2.52014889 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.28155375 |
| 13 | MP0008057_abnormal_DNA_replication | 2.22006659 |
| 14 | MP0002796_impaired_skin_barrier | 1.98354879 |
| 15 | MP0005076_abnormal_cell_differentiation | 1.96111479 |
| 16 | MP0010352_gastrointestinal_tract_polyps | 1.91735702 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 1.91610401 |
| 18 | MP0003941_abnormal_skin_development | 1.86210158 |
| 19 | MP0000609_abnormal_liver_physiology | 1.81592756 |
| 20 | MP0006138_congestive_heart_failure | 1.78528151 |
| 21 | MP0005083_abnormal_biliary_tract | 1.77185351 |
| 22 | MP0001666_abnormal_nutrient_absorption | 1.72780220 |
| 23 | MP0009053_abnormal_anal_canal | 1.68947855 |
| 24 | MP0004264_abnormal_extraembryonic_tissu | 1.54622297 |
| 25 | MP0000537_abnormal_urethra_morphology | 1.50501157 |
| 26 | MP0005332_abnormal_amino_acid | 1.46042773 |
| 27 | MP0000428_abnormal_craniofacial_morphol | 1.42484159 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.41578716 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.32692759 |
| 30 | MP0010030_abnormal_orbit_morphology | 1.32511695 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.32003777 |
| 32 | MP0001730_embryonic_growth_arrest | 1.28326489 |
| 33 | MP0002396_abnormal_hematopoietic_system | 1.27260476 |
| 34 | MP0000598_abnormal_liver_morphology | 1.25859940 |
| 35 | MP0003984_embryonic_growth_retardation | 1.25564343 |
| 36 | MP0003077_abnormal_cell_cycle | 1.25494169 |
| 37 | MP0002088_abnormal_embryonic_growth/wei | 1.25248585 |
| 38 | MP0002254_reproductive_system_inflammat | 1.25158252 |
| 39 | MP0004087_abnormal_muscle_fiber | 1.24737044 |
| 40 | MP0002086_abnormal_extraembryonic_tissu | 1.23676055 |
| 41 | MP0005380_embryogenesis_phenotype | 1.22738945 |
| 42 | MP0001672_abnormal_embryogenesis/_devel | 1.22738945 |
| 43 | MP0004957_abnormal_blastocyst_morpholog | 1.21404473 |
| 44 | MP0008961_abnormal_basal_metabolism | 1.19501655 |
| 45 | MP0003111_abnormal_nucleus_morphology | 1.18337608 |
| 46 | MP0004197_abnormal_fetal_growth/weight/ | 1.18070228 |
| 47 | MP0002118_abnormal_lipid_homeostasis | 1.18001388 |
| 48 | MP0003828_pulmonary_edema | 1.17912863 |
| 49 | MP0004858_abnormal_nervous_system | 1.16749396 |
| 50 | MP0010094_abnormal_chromosome_stability | 1.16295116 |
| 51 | MP0005248_abnormal_Harderian_gland | 1.15302409 |
| 52 | MP0003567_abnormal_fetal_cardiomyocyte | 1.14872384 |
| 53 | MP0003566_abnormal_cell_adhesion | 1.12522421 |
| 54 | MP0009278_abnormal_bone_marrow | 1.10327737 |
| 55 | MP0000462_abnormal_digestive_system | 1.10241779 |
| 56 | MP0001661_extended_life_span | 1.08918775 |
| 57 | MP0005670_abnormal_white_adipose | 1.07433220 |
| 58 | MP0004233_abnormal_muscle_weight | 1.07233103 |
| 59 | MP0000566_synostosis | 1.07154777 |
| 60 | MP0009672_abnormal_birth_weight | 1.07033365 |
| 61 | MP0005666_abnormal_adipose_tissue | 1.07021501 |
| 62 | MP0003878_abnormal_ear_physiology | 1.06698604 |
| 63 | MP0005377_hearing/vestibular/ear_phenot | 1.06698604 |
| 64 | MP0003890_abnormal_embryonic-extraembry | 1.06674986 |
| 65 | MP0003693_abnormal_embryo_hatching | 1.06261226 |
| 66 | MP0001286_abnormal_eye_development | 1.06253628 |
| 67 | MP0001849_ear_inflammation | 1.06000721 |
| 68 | MP0004185_abnormal_adipocyte_glucose | 1.04291354 |
| 69 | MP0005023_abnormal_wound_healing | 1.03220684 |
| 70 | MP0005451_abnormal_body_composition | 1.02697062 |
| 71 | MP0004272_abnormal_basement_membrane | 1.02260512 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 1.02103584 |
| 73 | MP0002138_abnormal_hepatobiliary_system | 1.02069572 |
| 74 | MP0001293_anophthalmia | 1.02055384 |
| 75 | MP0000350_abnormal_cell_proliferation | 1.01880670 |
| 76 | MP0001697_abnormal_embryo_size | 0.99001976 |
| 77 | MP0004019_abnormal_vitamin_homeostasis | 0.97766826 |
| 78 | MP0001544_abnormal_cardiovascular_syste | 0.96083870 |
| 79 | MP0005385_cardiovascular_system_phenoty | 0.96083870 |
| 80 | MP0002084_abnormal_developmental_patter | 0.95294636 |
| 81 | MP0002127_abnormal_cardiovascular_syste | 0.94690704 |
| 82 | MP0003303_peritoneal_inflammation | 0.90998336 |
| 83 | MP0003436_decreased_susceptibility_to | 0.90767154 |
| 84 | MP0003937_abnormal_limbs/digits/tail_de | 0.90312979 |
| 85 | MP0005501_abnormal_skin_physiology | 0.89473894 |
| 86 | MP0005397_hematopoietic_system_phenotyp | 0.89072918 |
| 87 | MP0001545_abnormal_hematopoietic_system | 0.89072918 |
| 88 | MP0000432_abnormal_head_morphology | 0.89025829 |
| 89 | MP0004782_abnormal_surfactant_physiolog | 0.88699723 |
| 90 | MP0003868_abnormal_feces_composition | 0.87760874 |
| 91 | MP0009697_abnormal_copulation | 0.87752142 |
| 92 | MP0005334_abnormal_fat_pad | 0.87326914 |
| 93 | MP0002085_abnormal_embryonic_tissue | 0.86237764 |
| 94 | MP0009643_abnormal_urine_homeostasis | 0.85213175 |
| 95 | MP0002080_prenatal_lethality | 0.84440660 |
| 96 | MP0003221_abnormal_cardiomyocyte_apopto | 0.83412862 |
| 97 | MP0002089_abnormal_postnatal_growth/wei | 0.83236465 |
| 98 | MP0000477_abnormal_intestine_morphology | 0.81993292 |
| 99 | MP0003935_abnormal_craniofacial_develop | 0.81777992 |
| 100 | MP0010630_abnormal_cardiac_muscle | 0.81651064 |
| 101 | MP0004130_abnormal_muscle_cell | 0.80929053 |
| 102 | MP0004808_abnormal_hematopoietic_stem | 0.80914451 |
| 103 | MP0010368_abnormal_lymphatic_system | 0.80742475 |
| 104 | MP0002166_altered_tumor_susceptibility | 0.79438806 |
| 105 | MP0004084_abnormal_cardiac_muscle | 0.78999763 |
| 106 | MP0008932_abnormal_embryonic_tissue | 0.78387855 |
| 107 | MP0000377_abnormal_hair_follicle | 0.77753384 |
| 108 | MP0002970_abnormal_white_adipose | 0.77496563 |
| 109 | MP0001915_intracranial_hemorrhage | 0.77421626 |
| 110 | MP0000751_myopathy | 0.77292912 |
| 111 | MP0010307_abnormal_tumor_latency | 0.76993177 |
| 112 | MP0003119_abnormal_digestive_system | 0.76196642 |
| 113 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.76176721 |
| 114 | MP0002019_abnormal_tumor_incidence | 0.75773415 |
| 115 | MP0005330_cardiomyopathy | 0.75282404 |
| 116 | MP0000685_abnormal_immune_system | 0.74875434 |
| 117 | MP0005220_abnormal_exocrine_pancreas | 0.73327697 |
| 118 | MP0005266_abnormal_metabolism | 0.72599136 |
| 119 | MP0002722_abnormal_immune_system | 0.72178100 |
| 120 | MP0000703_abnormal_thymus_morphology | 0.72007995 |
| 121 | MP0003186_abnormal_redox_activity | 0.71529927 |
| 122 | MP0009763_increased_sensitivity_to | 0.69873290 |
| 123 | MP0000689_abnormal_spleen_morphology | 0.69663542 |
| 124 | MP0000490_abnormal_crypts_of | 0.68604779 |
| 125 | MP0005464_abnormal_platelet_physiology | 0.66773756 |
| 126 | MP0000733_abnormal_muscle_development | 0.66397269 |
| 127 | MP0003763_abnormal_thymus_physiology | 0.65833239 |
| 128 | MP0003115_abnormal_respiratory_system | 0.65697733 |
| 129 | MP0002092_abnormal_eye_morphology | 0.65523480 |
| 130 | MP0009703_decreased_birth_body | 0.65356589 |
| 131 | MP0002398_abnormal_bone_marrow | 0.65343501 |
| 132 | MP0005375_adipose_tissue_phenotype | 0.62131350 |
| 133 | MP0002925_abnormal_cardiovascular_devel | 0.61784342 |
| 134 | MP0002269_muscular_atrophy | 0.61599951 |
| 135 | MP0009115_abnormal_fat_cell | 0.61519287 |
| 136 | MP0002971_abnormal_brown_adipose | 0.61210696 |
| 137 | MP0000266_abnormal_heart_morphology | 0.59028292 |
| 138 | MP0005647_abnormal_sex_gland | 0.58085782 |
| 139 | MP0002697_abnormal_eye_size | 0.57584751 |
| 140 | MP0004947_skin_inflammation | 0.57437043 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.27619069 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.64265426 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.61970557 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 4.14286784 |
| 5 | Xanthomatosis (HP:0000991) | 4.02316930 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.91597689 |
| 7 | Hepatoblastoma (HP:0002884) | 3.48915009 |
| 8 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.43953903 |
| 9 | Complement deficiency (HP:0004431) | 3.37524840 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 3.36399671 |
| 11 | Hyperammonemia (HP:0001987) | 3.26793706 |
| 12 | Hypolipoproteinemia (HP:0010981) | 3.03323567 |
| 13 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.03101217 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 3.03055778 |
| 15 | Ketosis (HP:0001946) | 2.99066242 |
| 16 | Hyperglycinemia (HP:0002154) | 2.98862135 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 2.93901726 |
| 18 | Neonatal hypoglycemia (HP:0001998) | 2.93275731 |
| 19 | High anterior hairline (HP:0009890) | 2.87785064 |
| 20 | Hypochromic microcytic anemia (HP:0004840) | 2.86282174 |
| 21 | Cortical dysplasia (HP:0002539) | 2.86071193 |
| 22 | Pseudobulbar signs (HP:0002200) | 2.82272981 |
| 23 | Metaphyseal cupping (HP:0003021) | 2.81025067 |
| 24 | Joint hemorrhage (HP:0005261) | 2.79360059 |
| 25 | Epidermoid cyst (HP:0200040) | 2.77236824 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.76919372 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 2.76394863 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.76394863 |
| 29 | Hyperglycinuria (HP:0003108) | 2.75067973 |
| 30 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.71758753 |
| 31 | Subaortic stenosis (HP:0001682) | 2.71758753 |
| 32 | Spastic diplegia (HP:0001264) | 2.68352970 |
| 33 | Delayed CNS myelination (HP:0002188) | 2.67476542 |
| 34 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.66281794 |
| 35 | Papillary thyroid carcinoma (HP:0002895) | 2.63181072 |
| 36 | Hypoalphalipoproteinemia (HP:0003233) | 2.61742328 |
| 37 | Difficulty running (HP:0009046) | 2.61063672 |
| 38 | Hypercholesterolemia (HP:0003124) | 2.60488130 |
| 39 | Abnormality of complement system (HP:0005339) | 2.60246034 |
| 40 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.59766135 |
| 41 | Gastrointestinal carcinoma (HP:0002672) | 2.59766135 |
| 42 | Asymmetry of the thorax (HP:0001555) | 2.58536985 |
| 43 | Hypoglycemic coma (HP:0001325) | 2.56429185 |
| 44 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.50746263 |
| 45 | Myocardial infarction (HP:0001658) | 2.45725715 |
| 46 | Esophageal varix (HP:0002040) | 2.42654018 |
| 47 | Disproportionate tall stature (HP:0001519) | 2.41098045 |
| 48 | Fat malabsorption (HP:0002630) | 2.35808362 |
| 49 | Abnormality of nucleobase metabolism (HP:0010932) | 2.34470063 |
| 50 | Embryonal renal neoplasm (HP:0011794) | 2.31791844 |
| 51 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.30821692 |
| 52 | Abnormality of the intrinsic pathway (HP:0010989) | 2.30561620 |
| 53 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.29128136 |
| 54 | Abnormality of methionine metabolism (HP:0010901) | 2.27894763 |
| 55 | Long eyelashes (HP:0000527) | 2.27269589 |
| 56 | Hepatocellular carcinoma (HP:0001402) | 2.26794753 |
| 57 | Ependymoma (HP:0002888) | 2.22264268 |
| 58 | Macroorchidism (HP:0000053) | 2.21124264 |
| 59 | Skull defect (HP:0001362) | 2.19241193 |
| 60 | Hyperbilirubinemia (HP:0002904) | 2.17719691 |
| 61 | Flat acetabular roof (HP:0003180) | 2.14055001 |
| 62 | Abnormal platelet volume (HP:0011876) | 2.11832704 |
| 63 | Increased mean platelet volume (HP:0011877) | 2.11288379 |
| 64 | Curly hair (HP:0002212) | 2.09483244 |
| 65 | Uterine leiomyosarcoma (HP:0002891) | 2.09092054 |
| 66 | Leiomyosarcoma (HP:0100243) | 2.09092054 |
| 67 | Hemangiomatosis (HP:0007461) | 2.08911563 |
| 68 | Reticulocytosis (HP:0001923) | 2.06450724 |
| 69 | Hypochromic anemia (HP:0001931) | 2.06304910 |
| 70 | Osteomalacia (HP:0002749) | 2.05150581 |
| 71 | Hyperacusis (HP:0010780) | 2.04381187 |
| 72 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.01599637 |
| 73 | Abnormality of purine metabolism (HP:0004352) | 2.00154486 |
| 74 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.99694927 |
| 75 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.99075258 |
| 76 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.97949580 |
| 77 | Germ cell neoplasia (HP:0100728) | 1.97675384 |
| 78 | Visceral angiomatosis (HP:0100761) | 1.97473489 |
| 79 | Back pain (HP:0003418) | 1.96295004 |
| 80 | Choanal stenosis (HP:0000452) | 1.95985990 |
| 81 | Cystic hygroma (HP:0000476) | 1.95067690 |
| 82 | Abnormality of the fingertips (HP:0001211) | 1.94783809 |
| 83 | Anal stenosis (HP:0002025) | 1.93037825 |
| 84 | Abnormal vertebral ossification (HP:0100569) | 1.92997602 |
| 85 | Lymphangioma (HP:0100764) | 1.91189538 |
| 86 | Skin nodule (HP:0200036) | 1.88177492 |
| 87 | Abnormality of the Achilles tendon (HP:0005109) | 1.86814126 |
| 88 | Arnold-Chiari malformation (HP:0002308) | 1.86292727 |
| 89 | Poikilocytosis (HP:0004447) | 1.85861091 |
| 90 | Diastasis recti (HP:0001540) | 1.85519079 |
| 91 | Ventricular tachycardia (HP:0004756) | 1.84837697 |
| 92 | Acute myeloid leukemia (HP:0004808) | 1.83748892 |
| 93 | Embryonal neoplasm (HP:0002898) | 1.83584263 |
| 94 | Polycythemia (HP:0001901) | 1.83402769 |
| 95 | Renovascular hypertension (HP:0100817) | 1.82980265 |
| 96 | Deep philtrum (HP:0002002) | 1.82732927 |
| 97 | Renal duplication (HP:0000075) | 1.82062703 |
| 98 | Urethral obstruction (HP:0000796) | 1.81419126 |
| 99 | Biliary tract neoplasm (HP:0100574) | 1.81410870 |
| 100 | Late onset (HP:0003584) | 1.78640956 |
| 101 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.78622282 |
| 102 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.78622282 |
| 103 | Abnormality of serum amino acid levels (HP:0003112) | 1.78621100 |
| 104 | Abnormal foot bone ossification (HP:0010675) | 1.78466188 |
| 105 | Right ventricular cardiomyopathy (HP:0011663) | 1.78107284 |
| 106 | Abnormal cartilage morphology (HP:0002763) | 1.77866939 |
| 107 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.77203157 |
| 108 | Gingival bleeding (HP:0000225) | 1.75836862 |
| 109 | Gout (HP:0001997) | 1.75610960 |
| 110 | Eczematoid dermatitis (HP:0000976) | 1.74801432 |
| 111 | Ankyloglossia (HP:0010296) | 1.73966392 |
| 112 | Abnormality of the salivary glands (HP:0010286) | 1.73647331 |
| 113 | Abnormality of the parathyroid morphology (HP:0011766) | 1.73112264 |
| 114 | Uterine neoplasm (HP:0010784) | 1.72844648 |
| 115 | Ketoacidosis (HP:0001993) | 1.72750839 |
| 116 | Mitral valve prolapse (HP:0001634) | 1.72515489 |
| 117 | Abnormal hair whorl (HP:0010721) | 1.71776778 |
| 118 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.71086046 |
| 119 | Bladder carcinoma (HP:0002862) | 1.71033692 |
| 120 | Bladder neoplasm (HP:0009725) | 1.71033692 |
| 121 | Abnormal tarsal ossification (HP:0008369) | 1.70900200 |
| 122 | Wide cranial sutures (HP:0010537) | 1.70869994 |
| 123 | Abnormality of iron homeostasis (HP:0011031) | 1.70321458 |
| 124 | Short 4th metacarpal (HP:0010044) | 1.70024647 |
| 125 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.70024647 |
| 126 | Abnormality of the 4th metacarpal (HP:0010012) | 1.69296976 |
| 127 | Rhabdomyosarcoma (HP:0002859) | 1.68869889 |
| 128 | Obsessive-compulsive behavior (HP:0000722) | 1.68670138 |
| 129 | Deviation of the thumb (HP:0009603) | 1.66841100 |
| 130 | Rectal prolapse (HP:0002035) | 1.65681598 |
| 131 | Cholelithiasis (HP:0001081) | 1.65621533 |
| 132 | Proximal placement of thumb (HP:0009623) | 1.65178496 |
| 133 | Skin tags (HP:0010609) | 1.64657559 |
| 134 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.64292794 |
| 135 | Malnutrition (HP:0004395) | 1.64096464 |
| 136 | Abnormality of the aortic arch (HP:0012303) | 1.63545707 |
| 137 | Multiple enchondromatosis (HP:0005701) | 1.62959101 |
| 138 | Metabolic acidosis (HP:0001942) | 1.62850445 |
| 139 | Neonatal onset (HP:0003623) | 1.62655218 |
| 140 | Thyroid carcinoma (HP:0002890) | 1.62596944 |
| 141 | Thrombophlebitis (HP:0004418) | 1.62327776 |
| 142 | Spinal cord lesions (HP:0100561) | 1.62284948 |
| 143 | Syringomyelia (HP:0003396) | 1.62284948 |
| 144 | Cutis marmorata (HP:0000965) | 1.61957277 |
| 145 | Steatorrhea (HP:0002570) | 1.61393383 |
| 146 | Increased variability in muscle fiber diameter (HP:0003557) | 1.61299726 |
| 147 | Abnormality of the calcaneus (HP:0008364) | 1.60761878 |
| 148 | Chin dimple (HP:0010751) | 1.60007014 |
| 149 | Hemorrhage of the eye (HP:0011885) | 1.58004896 |
| 150 | Acanthocytosis (HP:0001927) | 1.57737711 |
| 151 | Vertebral clefting (HP:0008428) | 1.57465840 |
| 152 | Abnormality of the lower motor neuron (HP:0002366) | 1.56602647 |
| 153 | Omphalocele (HP:0001539) | 1.56572925 |
| 154 | Menorrhagia (HP:0000132) | 1.56114442 |
| 155 | Hyperactive renin-angiotensin system (HP:0000841) | 1.56105164 |
| 156 | Hyporeflexia of lower limbs (HP:0002600) | 1.54771287 |
| 157 | Increased nuchal translucency (HP:0010880) | 1.54450424 |
| 158 | Mitral stenosis (HP:0001718) | 1.54004850 |
| 159 | Thin ribs (HP:0000883) | 1.53579842 |
| 160 | Broad palm (HP:0001169) | 1.53548410 |
| 161 | Coronal craniosynostosis (HP:0004440) | 1.53497703 |
| 162 | Long clavicles (HP:0000890) | 1.53264319 |
| 163 | Overgrowth (HP:0001548) | 1.52504999 |
| 164 | Renal cell carcinoma (HP:0005584) | 1.52450243 |
| 165 | Precocious puberty (HP:0000826) | 1.52165726 |
| 166 | Vertebral arch anomaly (HP:0008438) | 1.52160161 |
| 167 | Medulloblastoma (HP:0002885) | 1.52062796 |
| 168 | Ulnar bowing (HP:0003031) | 1.51270047 |
| 169 | Broad thumb (HP:0011304) | 1.51037995 |
| 170 | Increased serum ferritin (HP:0003281) | 1.50890449 |
| 171 | Sudden death (HP:0001699) | 1.50811617 |
| 172 | Neoplasm of the small intestine (HP:0100833) | 1.49908519 |
| 173 | Elfin facies (HP:0004428) | 1.49701033 |
| 174 | Preauricular skin tag (HP:0000384) | 1.49575990 |
| 175 | Prenatal maternal abnormality (HP:0002686) | 1.49476967 |
| 176 | Abnormal gallbladder morphology (HP:0012437) | 1.49137082 |
| 177 | Spontaneous hematomas (HP:0007420) | 1.48912674 |
| 178 | Absent eyebrow (HP:0002223) | 1.48611442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 5.44021582 |
| 2 | ERN1 | 4.14212510 |
| 3 | EEF2K | 3.54893294 |
| 4 | MAP3K10 | 3.31131158 |
| 5 | SMG1 | 3.29432912 |
| 6 | TRIB3 | 2.79095488 |
| 7 | PKN2 | 2.54810448 |
| 8 | SIK1 | 2.48396912 |
| 9 | ICK | 2.43552450 |
| 10 | BCKDK | 2.10254526 |
| 11 | NLK | 2.04010096 |
| 12 | YES1 | 1.95765229 |
| 13 | TAF1 | 1.92678300 |
| 14 | TAOK2 | 1.91047332 |
| 15 | FGFR4 | 1.89503603 |
| 16 | MAP4K1 | 1.81290649 |
| 17 | NEK2 | 1.67923269 |
| 18 | SIK3 | 1.67569909 |
| 19 | MAPKAPK3 | 1.62925413 |
| 20 | STK10 | 1.62056569 |
| 21 | LATS1 | 1.61850571 |
| 22 | MAP2K3 | 1.59492911 |
| 23 | LATS2 | 1.57451065 |
| 24 | PTK6 | 1.52509869 |
| 25 | BRD4 | 1.52508866 |
| 26 | GRK6 | 1.41972485 |
| 27 | CDK4 | 1.40837478 |
| 28 | CAMK1D | 1.39405139 |
| 29 | SGK2 | 1.39233475 |
| 30 | TTN | 1.37034094 |
| 31 | CDC7 | 1.35815565 |
| 32 | CDK6 | 1.30100916 |
| 33 | STK24 | 1.29652541 |
| 34 | * MTOR | 1.28351326 |
| 35 | SGK3 | 1.28305850 |
| 36 | KSR2 | 1.27608058 |
| 37 | PRPF4B | 1.26831525 |
| 38 | SCYL2 | 1.26123275 |
| 39 | RPS6KB2 | 1.25853069 |
| 40 | BMX | 1.23119780 |
| 41 | FLT3 | 1.20811459 |
| 42 | PAK4 | 1.17994979 |
| 43 | CDK7 | 1.16957973 |
| 44 | BRSK2 | 1.13979461 |
| 45 | PRKAA2 | 1.10924342 |
| 46 | TNIK | 1.09687539 |
| 47 | RIPK4 | 1.09621680 |
| 48 | AKT3 | 1.09340226 |
| 49 | WNK1 | 1.09242092 |
| 50 | LRRK2 | 1.08103480 |
| 51 | DYRK3 | 1.07875340 |
| 52 | MAPK11 | 0.99958432 |
| 53 | CDK19 | 0.98936459 |
| 54 | SGK494 | 0.97954338 |
| 55 | SGK223 | 0.97954338 |
| 56 | MAP3K11 | 0.96364943 |
| 57 | RET | 0.92987071 |
| 58 | STK3 | 0.89812826 |
| 59 | OBSCN | 0.88512051 |
| 60 | CAMK1G | 0.88191786 |
| 61 | PDGFRA | 0.87663159 |
| 62 | KSR1 | 0.86439311 |
| 63 | DMPK | 0.85672935 |
| 64 | NEK1 | 0.85520911 |
| 65 | TAOK3 | 0.85214443 |
| 66 | TYK2 | 0.84551634 |
| 67 | PIK3CA | 0.83929601 |
| 68 | RPS6KA4 | 0.83158445 |
| 69 | MAP3K2 | 0.80600485 |
| 70 | RIPK1 | 0.80338259 |
| 71 | ZAP70 | 0.79127740 |
| 72 | CSF1R | 0.77255982 |
| 73 | MELK | 0.76935012 |
| 74 | MKNK1 | 0.76330303 |
| 75 | PIM1 | 0.73398351 |
| 76 | MAP3K8 | 0.73273501 |
| 77 | MAP3K7 | 0.72360450 |
| 78 | STK4 | 0.72237567 |
| 79 | FGFR3 | 0.72229514 |
| 80 | TTK | 0.71840841 |
| 81 | MARK2 | 0.71535137 |
| 82 | PASK | 0.71346344 |
| 83 | BTK | 0.70803508 |
| 84 | ACVR1B | 0.67378136 |
| 85 | CHUK | 0.66226555 |
| 86 | FGFR1 | 0.66147058 |
| 87 | HIPK2 | 0.63293980 |
| 88 | MKNK2 | 0.63163535 |
| 89 | STK39 | 0.63118993 |
| 90 | STK38L | 0.61587800 |
| 91 | KDR | 0.60940456 |
| 92 | UHMK1 | 0.60876246 |
| 93 | CAMK4 | 0.60654163 |
| 94 | CHEK1 | 0.59964697 |
| 95 | CLK1 | 0.59516194 |
| 96 | DYRK1B | 0.58595956 |
| 97 | MAP3K3 | 0.57943398 |
| 98 | AKT2 | 0.57603167 |
| 99 | CSK | 0.57395220 |
| 100 | JAK3 | 0.57076078 |
| 101 | OXSR1 | 0.56412543 |
| 102 | TAOK1 | 0.56404084 |
| 103 | EIF2AK1 | 0.55874798 |
| 104 | ATR | 0.55847535 |
| 105 | ALK | 0.55412168 |
| 106 | PTK2 | 0.54111011 |
| 107 | PIK3CG | 0.53451439 |
| 108 | TGFBR2 | 0.52575292 |
| 109 | EPHA2 | 0.51988690 |
| 110 | ITK | 0.51707124 |
| 111 | JAK2 | 0.51395126 |
| 112 | EPHB2 | 0.49216186 |
| 113 | CDK2 | 0.48856361 |
| 114 | EPHA3 | 0.48789986 |
| 115 | PAK2 | 0.48299969 |
| 116 | TGFBR1 | 0.48023497 |
| 117 | RPS6KA1 | 0.47542087 |
| 118 | RPS6KC1 | 0.47254790 |
| 119 | RPS6KL1 | 0.47254790 |
| 120 | PDGFRB | 0.47193619 |
| 121 | MAP3K5 | 0.45095616 |
| 122 | PLK1 | 0.44775186 |
| 123 | EGFR | 0.43975088 |
| 124 | MAP3K6 | 0.43536586 |
| 125 | CASK | 0.43307481 |
| 126 | WEE1 | 0.41924401 |
| 127 | AURKB | 0.41820849 |
| 128 | RPS6KA6 | 0.41553289 |
| 129 | EPHB1 | 0.40495056 |
| 130 | MAPKAPK2 | 0.40410159 |
| 131 | SIK2 | 0.40118292 |
| 132 | STK11 | 0.39839218 |
| 133 | FGFR2 | 0.38883517 |
| 134 | TYRO3 | 0.38214478 |
| 135 | SRPK1 | 0.37580422 |
| 136 | TESK2 | 0.35902543 |
| 137 | PLK4 | 0.35785146 |
| 138 | ERBB2 | 0.34937534 |
| 139 | CDK1 | 0.34662891 |
| 140 | MAPK10 | 0.34472486 |
| 141 | TBK1 | 0.34336590 |
| 142 | AKT1 | 0.34118989 |
| 143 | MAPK1 | 0.32721266 |
| 144 | GSK3A | 0.32342057 |
| 145 | ATM | 0.31805849 |
| 146 | PRKAA1 | 0.29945021 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.32473810 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.29151061 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.12296616 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.95809757 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.62019948 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.38776985 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.27803719 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.26864132 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.09790775 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.05051247 |
| 11 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.04367778 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.03465878 |
| 13 | Lysine degradation_Homo sapiens_hsa00310 | 2.01015011 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.95363958 |
| 15 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.94326332 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.84961015 |
| 17 | Endometrial cancer_Homo sapiens_hsa05213 | 1.82985765 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.77124329 |
| 19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.68944540 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.68192425 |
| 21 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.62577332 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.61522033 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.50654881 |
| 24 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.46304595 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.45227021 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.43741295 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.42414717 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.41686107 |
| 29 | Prostate cancer_Homo sapiens_hsa05215 | 1.39831302 |
| 30 | Colorectal cancer_Homo sapiens_hsa05210 | 1.39084044 |
| 31 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.37071739 |
| 32 | Carbon metabolism_Homo sapiens_hsa01200 | 1.34978904 |
| 33 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.30346909 |
| 34 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.27984741 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.27421531 |
| 36 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.27368028 |
| 37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.26919529 |
| 38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.24312885 |
| 39 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.23291326 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.21576196 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.20768260 |
| 42 | Tight junction_Homo sapiens_hsa04530 | 1.18897337 |
| 43 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.14264588 |
| 44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.14192393 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.13674797 |
| 46 | Sulfur relay system_Homo sapiens_hsa04122 | 1.12950864 |
| 47 | Bile secretion_Homo sapiens_hsa04976 | 1.12112174 |
| 48 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.11253709 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.08898826 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.07970146 |
| 51 | Histidine metabolism_Homo sapiens_hsa00340 | 1.07376485 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.02236055 |
| 53 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.01635195 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98054341 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 0.96527743 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.94750668 |
| 57 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.94396419 |
| 58 | Retinol metabolism_Homo sapiens_hsa00830 | 0.94334550 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.93215653 |
| 60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.92813953 |
| 61 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.87150384 |
| 62 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.83924369 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83801472 |
| 64 | DNA replication_Homo sapiens_hsa03030 | 0.83542353 |
| 65 | Insulin resistance_Homo sapiens_hsa04931 | 0.82591417 |
| 66 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.80838966 |
| 67 | Glioma_Homo sapiens_hsa05214 | 0.77577087 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.76749544 |
| 69 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.76098353 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74260495 |
| 71 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.73454297 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72998956 |
| 73 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.70886205 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.68886755 |
| 75 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.68671822 |
| 76 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.68580408 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.68050153 |
| 78 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.67338518 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67039948 |
| 80 | Focal adhesion_Homo sapiens_hsa04510 | 0.66829014 |
| 81 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65641558 |
| 82 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64733631 |
| 83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64407839 |
| 84 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63437967 |
| 85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.63228034 |
| 86 | * Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.62615863 |
| 87 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61170977 |
| 88 | Adherens junction_Homo sapiens_hsa04520 | 0.60375959 |
| 89 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.59707229 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59510816 |
| 91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59244247 |
| 92 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58414384 |
| 93 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.58113227 |
| 94 | * RNA transport_Homo sapiens_hsa03013 | 0.58010427 |
| 95 | Base excision repair_Homo sapiens_hsa03410 | 0.57956984 |
| 96 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.55488511 |
| 97 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.54978803 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54606816 |
| 99 | Cell cycle_Homo sapiens_hsa04110 | 0.54254548 |
| 100 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.54101943 |
| 101 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.52792797 |
| 102 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51982375 |
| 103 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.50949642 |
| 104 | Melanogenesis_Homo sapiens_hsa04916 | 0.48781193 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48777336 |
| 106 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48536652 |
| 107 | Mismatch repair_Homo sapiens_hsa03430 | 0.48194523 |
| 108 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47158859 |
| 109 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.46975114 |
| 110 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.46968143 |
| 111 | Spliceosome_Homo sapiens_hsa03040 | 0.46786627 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45712623 |
| 113 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45397097 |
| 114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44717252 |
| 115 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.43575302 |
| 116 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.41822731 |
| 117 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.41390121 |
| 118 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.41387604 |
| 119 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39960093 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39393611 |
| 121 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38613035 |
| 122 | Thyroid cancer_Homo sapiens_hsa05216 | 0.37409111 |
| 123 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36822302 |
| 124 | Bladder cancer_Homo sapiens_hsa05219 | 0.36676979 |
| 125 | Viral myocarditis_Homo sapiens_hsa05416 | 0.36433735 |
| 126 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.35795756 |
| 127 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.34730175 |
| 128 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34542385 |
| 129 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.33026656 |
| 130 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31537186 |
| 131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30206956 |
| 132 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.29931720 |
| 133 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.29759298 |
| 134 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.27721712 |
| 135 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.27700869 |
| 136 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.27462329 |
| 137 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.26877741 |

